A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAstraZeneca
About this trial
This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.
Eligibility criteria
Qualifiers
Participant must be 16 years of age or older, at the time of signing the informed consent.
Participants with a documented diagnosis of CRSwNP.
Endoscopic nasal polypectomy is performed during the screening period.
Voluntarily participate and sign the informed consent form as described in A 3.
Disqualifiers
Any significant disease or disorder that the investigator believes may place the patient at risk or may affect the study results or the patient's ability to participate in the study.
Currently participating in an interventional study.
Patients who are unable to independently complete questionnaires due to language barriers or mental status.
Trial design
Treatments tested in this trial
- Endoscopic Sinus Surgery (ESS)
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov